NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Gameto

Gameto

Private
Austin, TexasHealthcare & Life Scienceshttps://www.gametogen.com/

Last Round

Series C

Aug 12, 2025

Est. Valuation

$243M

Total Funding Raised

$127M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Gameto is a biotechnology company that develops cell engineering platforms to create novel treatments for women's reproductive health, including infertility and ovarian aging.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

in-vitro maturationIVMfertility treatmentegg freezingassisted reproductive technologyARTIVFbiotechnologyovarian healthcell engineeringfertility techfemtechmedical devicecell therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gameto Comps

Public and private peers based on sector, stage, and business model.

Gameto comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gameto Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CAug 12, 2025
GrantOct 23, 2024
Series BMay 29, 2024
Series A ExtensionSep 14, 2022
Series AJan 10, 2022
Seed
Mar 1, 2020

Key People

Founding team and executive leadership

Dina Radenkovic Turner

Co-founder CEO

Founding Team

Gameto Investors

Notable investors and investment history

Gameto investors
InvestorRounds
RA Capital ManagementSeries C, Series B
Future VenturesSeries B, Series C, Series A Extension, Series A
Khosla VenturesSeries C
Pontiva Healthcare PartnersSeries C
GaingelsSeries A Extension
PortfoliaSeries C
Pags GroupSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 43% MoM, reaching 7.8K.

  • Mar 1, 2026

    Selected for ARPA-H Sprint for Women’s Health support.

Gameto Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gameto Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gameto's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range61
Year Founded2020
Last FundingAug 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.